<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM 10-Q FOR THE PERIOD ENDED SEPTEMBER 30, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <MULTIPLIER> 1,000 <PERIOD-TYPE> 9-MOS <F1> <FISCAL-YEAR-END> DEC-31-1999 <PERIOD-START> JAN-01-1999 <PERIOD-END> SEP-30-1999 <CASH> 8,009 <SECURITIES> 2,996 <RECEIVABLES> 3,287 <F2> <ALLOWANCES> 0 <INVENTORY> 2,386 <CURRENT-ASSETS> 17,267 <PP&E> 2,224 <F2> <DEPRECIATION> 0 <TOTAL-ASSETS> 23,601 <CURRENT-LIABILITIES> 5,400 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 129 <OTHER-SE> 18,047 <TOTAL-LIABILITY-AND-EQUITY> 23,601 <SALES> 15,808 <TOTAL-REVENUES> 20,201 <CGS> 11,169 <TOTAL-COSTS> 13,033 <OTHER-EXPENSES> 4,779 <F3> <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 0 <INCOME-PRETAX> (14,763) <INCOME-TAX> 61 <INCOME-CONTINUING> (14,824) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (14,824) <EPS-BASIC> (1.23) <F4> <EPS-DILUTED> (1.23) <FN> <F1> The 13-week period from July 4, 1999 to October 2, 1999 is referred to herein as the three months ended September 30, 1999. The 39-week period from January 3, 1999 to October 2, 1999 is referred to herein as the nine months ended September 30, 1999. Year-to-date data is for quarters presented. <F2> Item shown net of allowance, consistent with the balance sheet presentation. <F3> Item consists of research and development. <F4> Item consists of basic earnings per share. </FN>